Blue Bird (NASDAQ:BLBD) Cut to “Strong Sell” at ValuEngine
A number of other research firms have also recently weighed in on BLBD. Zacks Investment Research raised shares of Blue Bird from a “strong sell” rating to a “hold” rating in a research note on Friday, July 12th. BidaskClub cut shares of Blue Bird from a “buy” rating to a “hold” rating in a research note on Tuesday. Finally, Stifel Nicolaus raised shares of Blue Bird from a “hold” rating to a “buy” rating and upped their target price for the company from $21.00 to $23.00 in a research note on Monday, May 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. Blue Bird presently has a consensus rating of “Hold” and an average price target of $22.50.
NASDAQ BLBD traded down $0.06 on Tuesday, reaching $17.62. The company’s stock had a trading volume of 51,295 shares, compared to its average volume of 75,821. The stock has a market capitalization of $466.51 million, a price-to-earnings ratio of 10.36 and a beta of 0.98. The company’s 50-day moving average price is $19.55. Blue Bird has a 52 week low of $15.67 and a 52 week high of $26.95.
Institutional investors have recently modified their holdings of the business. Bank of Montreal Can grew its stake in Blue Bird by 18,057.1% during the second quarter. Bank of Montreal Can now owns 1,271 shares of the company’s stock worth $25,000 after buying an additional 1,264 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Blue Bird by 52.1% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,165 shares of the company’s stock worth $37,000 after buying an additional 742 shares during the last quarter. Exane Derivatives bought a new stake in Blue Bird during the second quarter worth about $60,000. BNP Paribas Arbitrage SA grew its stake in Blue Bird by 901.3% during the first quarter. BNP Paribas Arbitrage SA now owns 3,174 shares of the company’s stock worth $54,000 after buying an additional 2,857 shares during the last quarter. Finally, Metropolitan Life Insurance Co. NY grew its stake in Blue Bird by 285.5% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 4,287 shares of the company’s stock worth $78,000 after buying an additional 3,175 shares during the last quarter. 98.23% of the stock is currently owned by hedge funds and other institutional investors.
Blue Bird Company Profile
Blue Bird Corporation designs, engineers, manufactures, and sells school buses and related parts in the United States, Canada, and internationally. It operates through two segments, Bus and Parts. The company offers Type C, Type D, and specialty buses; and alternative fuel applications through its propane-powered, gasoline-powered, compressed natural gas-powered, and electric powered school buses.
Recommended Story: What is the QQQ ETF?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Blue Bird Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Bird and related companies with MarketBeat.com's FREE daily email newsletter.